首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1578730

2024 年胰島素輸送設備全球市場報告

Insulin Delivery Devices Global Market Report 2024

出版日期: 2024年10月28日 | 出版商:

The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

胰島素輸送設備市場規模預計在未來幾年將強勁成長。 2028年，將以8.3%的複合年成長率成長至243.2億美元。預測期內的成長是由糖尿病盛行率不斷上升、糖尿病治療醫療費用不斷上升、連續血糖監測系統的擴展、患者對自動胰島素輸送設備益處的認知不斷提高以及對醫療保健的日益關注所推動的。是由於這個原因。預計這段時期的主要趨勢包括胰島素輸送設備的技術進步、這些設備與數位技術的整合、人工胰臟系統的開發以及胰島素管理和仿生技術的進步。

糖尿病盛行率的增加預計將在未來幾年推動胰島素輸送設備市場的成長。糖尿病是一種慢性疾病，其特徵是由於胰臟分泌胰島素不足或人體無法有效利用胰島素而導致血糖值升高。糖尿病患者數量的增加很大程度上是由於久坐的生活方式、不良的飲食習慣以及全球肥胖率上升等因素造成的。胰島素輸送裝置對於治療糖尿病至關重要。因為透過控制和方便地注射胰島素，可以有效控制血糖值，預防併發症，促進整體健康。例如，根據美國疾病管制與預防中心的數據，截至2022年12月，美國20歲以下2型糖尿病患者數量到2060年將增加近700%，達到22萬人。此外，同期年輕人中 1 型糖尿病的診斷可能會增加 65%。糖尿病盛行率的不斷上升正在推動胰島素輸送設備市場的擴張。

胰島素輸送設備市場的主要企業專注於開發創新產品，例如提供持續或可客製化胰島素輸送的胰島素幫浦。胰島素幫浦是一種可程式設計醫療設備，可透過放置在皮下的導管連續或按需輸送胰島素。例如，2023年5月，美國醫療科技公司Beta Bionics的iLet ACE Pump和iLet Dosing Decision Software獲得美國食品藥物管理局的核准。 iLet Bionic Pancreas 系統專為 6 歲及以上 1 型糖尿病患者設計，將兩個裝置與經 FDA 批准的兼容整合式連續血糖監測儀 (iCGM) 整合在一起。該系統使用由自適應閉合迴路演算法驅動的自動胰島素給藥（AID）系統進行操作，僅需要用戶的體重進行設置，無需額外的胰島素給藥參數。與傳統的泵療法不同，該系統不需要手動設定調整，因此易於啟動和管理。此外，iLet 設備還引入了用餐通知功能，透過將用餐分為小餐、中餐和大餐來簡化用餐時的胰島素管理。

全球胰島素輸送設備市場：按類型分類的績效與預測，2018-2023、2023-2028F、2033F
胰島素注射器
胰島素噴射注射器
筆針
可重複使用的胰島素筆
拋棄式胰島素筆
胰島素幫浦
外部或繫留泵
貼片幫浦
全球胰島素輸送設備市場：依疾病適應症分類的表現與預測，2018-2023、2023-2028F、2033F
類型1
2型
全球胰島素輸送設備市場：按分銷管道分類的實際情況和預測，2018-2023、2023-2028F、2033F
醫院藥房
零售藥房
網上銷售
糖尿病診所或中心

第 7 章區域/國家分析

全球胰島素輸送設備市場：按地區分類的績效與預測，2018-2023、2023-2028F、2033F
全球胰島素輸送設備市場：按國家分類的績效和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭格局及公司概況

胰島素輸送裝置市場：競爭格局
胰島素輸送設備市場：公司簡介
- Sanofi SA
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Medtronic Plc
- Eli Lilly and Company

第31章其他重大及創新企業

Novo Nordisk A/S
Becton, Dickinson and Company
EOFlow Co. Ltd.
Insulet Corporation
Tandem Diabetes Care Inc.
Ypsomed Holding AG
Xeris Pharmaceuticals Inc.
Beta Bionics Inc.
Zealand Pharma AS
Bigfoot Biomedical Inc.
Emperra GmbH
Animas Corporation
Debiotech SA
CeQur Corporation
Aerami Therapeutics Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄

Product Code: r19940

Insulin delivery devices are medical tools designed to administer insulin to individuals with diabetes. These devices are essential for managing blood glucose levels in people who are unable to produce sufficient insulin naturally. They help control blood sugar levels effectively, offering flexibility and convenience in insulin administration.

The primary types of insulin delivery devices include insulin syringes, insulin jet injectors, pen needles, reusable insulin pens, disposable insulin pens, insulin pumps, external or tethered pumps, and patch pumps. Insulin syringes, in particular, are designed for the subcutaneous injection of insulin, featuring fine, short needles and clearly marked dosage indicators to ensure precise hormone delivery. These devices are used for both type 1 and type 2 diabetes and are available through various channels, including hospital pharmacies, retail pharmacies, online sales, and diabetes clinics or centers.

The insulin delivery devices market research report is one of a series of new reports from The Business Research Company that provides insulin delivery devices market statistics, including insulin delivery devices industry global market size, regional shares, competitors with a insulin delivery devices market share, detailed insulin delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the insulin delivery devices industry. This insulin delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The insulin delivery devices market size has grown strongly in recent years. It will grow from $16.38 billion in 2023 to $17.71 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period can be attributed to the convenience and ease of use provided by insulin delivery devices, favorable reimbursement policies, the rising prevalence of obesity, an aging population, and the increasing adoption of insulin pumps.

The insulin delivery devices market size is expected to see strong growth in the next few years. It will grow to $24.32 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the increasing prevalence of diabetes, rising healthcare expenditure on diabetes care, the expansion of continuous glucose monitoring systems, growing patient awareness of the benefits of automated insulin delivery devices, and an increased focus on healthcare. Key trends expected during this period include technological advancements in insulin delivery devices, the integration of digital technology with these devices, the development of artificial pancreas systems, and progress in both insulin administration and bionic technologies.

The increasing prevalence of diabetes is expected to drive the growth of the insulin delivery device market in the coming years. Diabetes is a chronic condition characterized by elevated blood sugar levels due to either insufficient insulin production by the pancreas or the body's inability to effectively use insulin. The rise in diabetes cases is largely attributed to factors such as sedentary lifestyles, poor diets, and increasing obesity rates worldwide. Insulin delivery devices are essential for managing diabetes, as they allow individuals to control their blood sugar levels effectively by administering insulin in a controlled and convenient manner, thus preventing complications and promoting overall health. For example, according to the Centers for Disease Control and Prevention, a U.S.-based government agency, as of December 2022, the number of young people under 20 with type 2 diabetes in the United States could increase by nearly 700% by 2060, potentially reaching 220,000 individuals. Additionally, diagnoses of type 1 diabetes among young people could rise by as much as 65% over the same period. This growing prevalence of diabetes is fueling the expansion of the insulin delivery device market.

Leading companies in the insulin delivery device market are focusing on developing innovative products, such as insulin pumps, which provide continuous or customizable insulin delivery. Insulin pumps are programmable medical devices that deliver insulin continuously or on demand through a catheter placed under the skin. For instance, in May 2023, Beta Bionics, a U.S.-based medical technology company, received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system, designed for individuals aged six and older with type 1 diabetes, integrates two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). This system operates using an automated insulin dosing (AID) system driven by an adaptive closed-loop algorithm, which only requires the user's body weight for setup and eliminates the need for additional insulin dosing parameters. Unlike traditional pump therapy, this system requires no manual adjustment of settings, making it easier to initiate and manage. Additionally, the iLet device introduces a meal announcement feature that simplifies mealtime insulin dosing by categorizing meals as small, medium, or large, with the algorithm learning and adapting to individual insulin needs over time.

In September 2023, Abbott, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by expanding its renowned FreeStyle Libre portfolio of continuous glucose monitoring technology. The move aligns with Abbott's strategy to advance connected solutions, aiming to personalize and refine diabetes management. Bigfoot Biomedical is a U.S.-based manufacturer of insulin delivery devices.

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the insulin delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The insulin delivery devices market consists of sales of insulin infusion sets, insulin reservoirs, insulin pump accessories, and insulin cartridges. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Insulin Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on insulin delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for insulin delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The insulin delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Insulin Syringes; Insulin Jet Injectors; Pen Needles; Reusable Insulin Pens; Disposable Insulin Pens; Insulin Pumps; External Or Tethered Pumps; Patch Pumps
2) By Disease Indication: Type 1; Type 2
3) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Sales; Diabetes Clinics Or Centers
Companies Mentioned: Sanofi SA; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Medtronic Plc; Eli Lilly and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Insulin Delivery Devices Market Characteristics

3. Insulin Delivery Devices Market Trends And Strategies

4. Insulin Delivery Devices Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Insulin Delivery Devices Market Size and Growth

5.1. Global Insulin Delivery Devices Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Insulin Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Insulin Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Insulin Delivery Devices Market Segmentation

6.1. Global Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Insulin Syringes
Insulin Jet Injectors
Pen Needles
Reusable Insulin Pens
Disposable Insulin Pens
Insulin Pumps
External Or Tethered Pumps
Patch Pumps
6.2. Global Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Type 1
Type 2
6.3. Global Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Sales
Diabetes Clinics Or Centers

7. Insulin Delivery Devices Market Regional And Country Analysis

7.1. Global Insulin Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Insulin Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Insulin Delivery Devices Market

8.1. Asia-Pacific Insulin Delivery Devices Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Insulin Delivery Devices Market

9.1. China Insulin Delivery Devices Market Overview
9.2. China Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Insulin Delivery Devices Market

10.1. India Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Insulin Delivery Devices Market

11.1. Japan Insulin Delivery Devices Market Overview
11.2. Japan Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Insulin Delivery Devices Market

12.1. Australia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Insulin Delivery Devices Market

13.1. Indonesia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Insulin Delivery Devices Market

14.1. South Korea Insulin Delivery Devices Market Overview
14.2. South Korea Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Insulin Delivery Devices Market

15.1. Western Europe Insulin Delivery Devices Market Overview
15.2. Western Europe Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Insulin Delivery Devices Market

16.1. UK Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Insulin Delivery Devices Market

17.1. Germany Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Insulin Delivery Devices Market

18.1. France Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Insulin Delivery Devices Market

19.1. Italy Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Insulin Delivery Devices Market

20.1. Spain Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Insulin Delivery Devices Market

21.1. Eastern Europe Insulin Delivery Devices Market Overview
21.2. Eastern Europe Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Insulin Delivery Devices Market

22.1. Russia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Insulin Delivery Devices Market

23.1. North America Insulin Delivery Devices Market Overview
23.2. North America Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Insulin Delivery Devices Market

24.1. USA Insulin Delivery Devices Market Overview
24.2. USA Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Insulin Delivery Devices Market

25.1. Canada Insulin Delivery Devices Market Overview
25.2. Canada Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Insulin Delivery Devices Market

26.1. South America Insulin Delivery Devices Market Overview
26.2. South America Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Insulin Delivery Devices Market

27.1. Brazil Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Insulin Delivery Devices Market

28.1. Middle East Insulin Delivery Devices Market Overview
28.2. Middle East Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Insulin Delivery Devices Market

29.1. Africa Insulin Delivery Devices Market Overview
29.2. Africa Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Insulin Delivery Devices Market Competitive Landscape And Company Profiles

30.1. Insulin Delivery Devices Market Competitive Landscape
30.2. Insulin Delivery Devices Market Company Profiles
- 30.2.1. Sanofi SA
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Abbott Laboratories
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Medtronic Plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Eli Lilly and Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Insulin Delivery Devices Market Other Major And Innovative Companies

31.1. Novo Nordisk A/S
31.2. Becton, Dickinson and Company
31.3. EOFlow Co. Ltd.
31.4. Insulet Corporation
31.5. Tandem Diabetes Care Inc.
31.6. Ypsomed Holding AG
31.7. Xeris Pharmaceuticals Inc.
31.8. Beta Bionics Inc.
31.9. Zealand Pharma AS
31.10. Bigfoot Biomedical Inc.
31.11. Emperra GmbH
31.12. Animas Corporation
31.13. Debiotech SA
31.14. CeQur Corporation
31.15. Aerami Therapeutics Inc.

32. Global Insulin Delivery Devices Market Competitive Benchmarking

33. Global Insulin Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Insulin Delivery Devices Market

35. Insulin Delivery Devices Market Future Outlook and Potential Analysis

35.1 Insulin Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
35.2 Insulin Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
35.3 Insulin Delivery Devices Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies